1 of 30

RAFAT MOHEBBI FAR, FATEMEH SAMIEE RAD, ZAHRA ABDOLAZIMI, MOHAMAD MEHDI DANESHI KOHAN�QAZVIN UNIVERSITY OF MEDICAL SCIENCES, �DEPARTMENT OF HEALTH MANAGEMENT, �METABOLIC RESEARCH CENTER, DEPARTMENT OF PATHOLOGY, �MASTER OF HEALTH MANAGEMENT�DEPARTMENT OF LABORATORY, �PUBLISH 2014

Determination of Rate and Causes of Wastage of�Blood and Blood Products in

Iranian Hospitals

AHMAD ZA’IM BIN AZIZ

JURUTEKNOLOGI MAKMAL PERUBATAN U29

MAKMAL TRANSFUSI KLINIKAL,HTA

2 of 30

SOCIAL BACKGROUND QAZWIN�*Located in 150 km northwest of Tehran, �*it is at an altitude of about 1,800 m (5,900 ft) above sea level. �*The climate is cold but dry, �*The majority of the people of the city of Qazvin are Persians�*Area City 64.132 km2 �* Population402,748 (2016)

WHERE QAZWIN, IRAN

3 of 30

INTRODUCTION

  • Blood transfusion is an essential part in patient treatment.

  • Increase life expectency and advances in medical technology are several factors involved in the continuing need for blood and blood product.

4 of 30

INTRODUCTION cont.

  • The only source of blood products are from human which has been steadily declining in term of the numbers of donor.

  • The reasons is in increase of donors’ age, stricter parameters for the acceptance of donors and many more.

  • Thus, realising this challenges, maintaining and utilizing this precious resources is very important on doing so.

  • All this is in the confinement of financial, material resources and realistic plan of action based on actual description and analysis of existing conditions in each country.

5 of 30

OBJECTIVE

  • The purpose of this study is to determine the rate and wastage of blood and blood products(packed red cells, plasma, platelets, and cryoprecipitate)

  • Location: hospitals in qazvin, iran. 12 hospitals(5 teaching hospitals, 3 private hospitals, 2 social welfare hospitals, 1 charity hospital, and 1 military hospital)

6 of 30

MATERIALS AND METHODS (1/3)

  • Cross-sectional, analytical-descriptive studybased on the statistical data available from hospitals’ bloodbanks.
  • Data about blood and blood component wastage for the year 2010
  • The research instrument was a 2-part questionnaire.
  • The first part was related to demographic characteristics of the hospitals and the second part elicited information about blood and blood component wastage;

7 of 30

MATERIALS AND METHOD (2/3)

  • the data were taken from detailed forms of unused blood and blood components, categorized into 6 sections:

*type of blood product,

* blood groups,

*number of requested units,

*number of blood transfusion units,

* number of wasted blood units,

*reason for wastage.

8 of 30

MATERIALS AND METHOD (3/3)

  • Thus, the evaluation was retrospective. In order to complete the questionnaire, data were gathered by contacting the blood banks of the hospitals under study, conducting interviews with the people in charge of those departments, and studying the patients’ documents.
  • The collected data were then analyzed using descriptive statistical methods and SPSS 11.5.

9 of 30

  • TOTAL NUMBER OF BLOOD RECEIVED IN ALL HOSPITALS OF QAZVIN PROVINCE : 30913 UNIT.

10 of 30

Blood

Unit

Used

27865

Discard

3048

11 of 30

Hospitals

Teaching

Private

Social welfare

Charity

Military

Transfused

18 203

6 152

4 885

990

587

Discard

1 777

607

482

98

58

12 of 30

13 of 30

14 of 30

FINDINGS

Blood and blood product wastage due to:

  • Expiration of the usability period
  • The patient’s lack of need for these products
  • Blood medically and surgically ordered but not used
  • Stock time expired (overweight blood bag – doe 14 days)
  • Hemolysis
  • Miscellaneous reasons

15 of 30

CONCLUSION

  • Wastage at all hospitals averaged 9.8% among 30193 issued blood products.

  • The blood transfusion system has made significant advancement is areas such as
    • Storage of blood
    • Cross-matching
    • Rational use of blood
    • Distribution.

16 of 30

CONCLUSION cont.

  • In order to improve the standards of blood bank and blood tranfusion service in iran, comprehensive standards have been formulated.

  • To ensure better quality control in collection, storage, testing, and distribution of blood and its components for the identified major factors affecting blood product wastage.

17 of 30

DATA FROM CTD

  • Discarded Blood Bags : By reasons
  • Discarded Blood Bags : By Component Product
  • 5 mains reasons of discarded : By Components
      • Expired
      • Unsuitable for reuse
      • Broken / Leaking
      • Expired – Irradiated
      • Contains foreign particles

*Data From Teknikal Meeting CTD September 2021

18 of 30

Discarded Blood Bags : By reasons JAN –SEP 2021

19 of 30

Discarded Blood Bags by Component Product:� Jan. – Sep. 2021

20 of 30

5 mains reasons of discarded : �By components JAN – SEP 2021

21 of 30

5 mains reasons of discarded : �By components JAN – SEPT 2021

22 of 30

5 mains reasons of discarded : �By components JAN – SEPT 2021

23 of 30

Price for Private Hospital

  • GXM 2 pint RM135

  • Blood Bag RM30/Bag

  • Reagent RM 75 for 2 pint packed cell (ABO grouping,Antibody Screening,Crossmatching)

24 of 30

1)Case Study Crossmatch :Transfused Ratio (C:T)

  • If 1 pint blood bag can recrossmatching 6 time
  • So C:T Ratio is 6:1
  • 5 time crossmatching is wastage( cost and man power)
  • If costing crossmatching equal RM 75(Reagent,Antisera,Gel Card)
  • Mean CTD wastage 5 x Rm75 = Rm375

25 of 30

CTD BLOOD SUPPLY AND BLOOD RETURN JAN – OCT 2021

*PERCENTAGE BLOOD RETURN 34%

26 of 30

Convert Total Blood Bag Return to �Ringgit Malaysia(RM)

  • If 19251 blood bag return
  • Costing gxm for 1 patient used 2 pint blood rm135
  • Exclude blood bag cost rm30/bag = rm75
  • Average 1 patient used 2 pint bag
  • If 19251 /2 bag = 9626 patient used
  • 9626 patient x RM75 = RM721 952.00 wastage cost
  • Equal 3 Bitcoin

27 of 30

2)Case Study Of Blood Bag Return Because �RN Not Tally

  • Example
    • A&E department using TEMPORARY RN
    • After patient allow to admit ward
    • Patient will registered at “Unit Pendaftaran Kemasukan Wad”
    • Patient will get new RN

28 of 30

Reason blood return not used

BEFORE ADMIT WAD

AFTER ADMIT WAD

CHECKING LIST BEFORE TRANSFUSED BLOOD

  1. NAME
  2. IC NUMBER
  3. RN NUMBER X

CHECKING LIST BEFORE TRANSFUSED BLOOD

  1. FORM GXM
  2. STICKER PPDK BAG
  3. BHT PATIENT X

29 of 30

SUGGESTION

  1. Educate ward

(Make template or video for transporting and collecting blood)

  • Monitor blood return especially <24 hour after gxm
  • Suggest A&E department not to send GSH with no RN number

(Double sample with different RN)

  • Limiting reused blood

(Quality preservation – hemolysed)

  • To scan the temperature of blood bag after release from ward

(using infrared thermometer- <8°c)

30 of 30